Ckim Pharma LLP - pharma in Namchi, Sikkim, India. FY 2026 financials & compliance.
LLPIN AAI-2659 Incorporated 13 January 2017 ROC Kolkata HQ Namchi, Sikkim, India
Active Limited Liability Partnership pharma
Revenue · FY 2023
₹14.59 Lakh
▲ 32% YoY
Net loss · FY 2023
₹31.74 Lakh
Net margin -217.5%
EBITDA · FY 2023
-₹11.66 Lakh
EBITDA margin -79.9%
Contribution obligation
₹1 Cr
As per LLP agreement
LLP age
9 yrs
Est. 2017
Designated partners
4
As per MCA filings
Active GSTINs
2
GST registered
Last financials
Mar 2025
Balance sheet date

About Ckim Pharma LLP

Data last updated:

Ckim Pharma LLP is a limited liability partnership (LLP) based in Namchi, Sikkim, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2017 and has been in existence for over 9 years.

The LLP is registered with the Registrar of Companies (ROC), Kolkata, under LLPIN AAI-2659. Its GSTIN is 11AALFC9867E1ZB (Sikkim). The LLP holds 2 GST registrations, all of them active.

The LLP has a total obligation of contribution of ₹1 Cr. It is led by designated partners including Shankar Agarwal and Hemant Amrish Parikh.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Namchi Bazar Namchi, Sikkim, India – 737126.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹14.59 Lakh, a growth of 32% compared to the previous year. For the same year it recorded a net loss of ₹31.74 Lakh (net margin -217.5%) and EBITDA of -₹11.66 Lakh (EBITDA margin -79.9%). Revenue has grown at a compounded annual rate (CAGR) of 277% over three years and 81% over five years.

Company details

LLPIN AAI-2659
Incorporation Date 13 January 2017
Total Obligation of Contribution ₹1 Cr
ROC Kolkata
Company Status Active

Contact details

Ckim Pharma LLP's registered office is in Namchi, Sikkim. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Namchi Bazar Namchi, Sikkim, India – 737126
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Ckim Pharma LLP, buy the company report.

Comprehensive company report
Ckim Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Ckim Pharma LLP

FY 2025 filings available

Ckim Pharma LLP reported revenue of ₹14.59 Lakh (up 32% YoY) for FY 2023.

Revenue · FY 2023
₹14.59 Lakh ▲ 32%
Net loss · FY 2023
₹31.74 Lakh margin -217.5%
EBITDA · FY 2023
-₹11.66 Lakh margin -79.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 277%
5 years · compounded
▲ 81%

Revenue has grown at a compounded annual rate (CAGR) of 81% over five years, including 32% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax-₹31.74 Lakh
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin-217.5%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Ckim Pharma LLP, buy the company report.

Designated partners of Ckim Pharma LLP

Ckim Pharma has 4 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Shankar AgarwalDesignated Partner13 Jan 20179 Years 10 MonthsCurrent
Hemant Amrish ParikhDesignated Partner14 Aug 20206 Years 3 MonthsCurrent
Girish BhattDesignated Partner14 Aug 20206 Years 3 MonthsCurrent
Mahabir Agarwal PrasadDesignated Partner13 Jan 20179 Years 10 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ckim Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ckim Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
11AALFC9867E1ZBSikkimActive01 Jul 2017
24AALFC9867E1Z4GujaratActive08 Jan 2021

To see the full GST registrations and return filing status of Ckim Pharma LLP, buy the company report.

Recent activity

Ckim Pharma LLP has 5 designated partner changes on record since 2017: 4 appointments and 1 cessation. The latest: Girish Bhatt was appointed as Designated Partner on 14 Aug 2020.

AGM
Ckim Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Ckim Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Appointed
Girish Bhatt was appointed as Designated Partner.
Appointed
Hemant Amrish Parikh was appointed as Designated Partner.
Ceased
Harsh Kumar Doshi ceased to be Designated Partner.
Appointed
Mahabir Agarwal Prasad was appointed as Designated Partner.
Appointed
Shankar Agarwal was appointed as Designated Partner.
Incorporation
13 Jan 2017
Ckim Pharma Llp was registered on 13 Jan 2017 with Roc Kolkata & aged 9 years 10 months as per MCA records.

Frequently asked questions

Ckim Pharma is an active limited liability partnership based in Namchi, Sikkim, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2017 (9+ years old) and is registered under LLPIN AAI-2659.

Ckim Pharma has 4 current designated partners:

The latest financial statements of Ckim Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Ckim Pharma is 11AALFC9867E1ZB, registered in Sikkim. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AALFC9867E1Z4 (Gujarat).

The LLPIN (Limited Liability Partnership Identification Number) of Ckim Pharma is AAI-2659. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Ckim Pharma was incorporated on 13 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.

Girish Bhatt was appointed as Designated Partner on 14 Aug 2020. Hemant Amrish Parikh was appointed as Designated Partner on 14 Aug 2020. Harsh Kumar Doshi ceased to be Designated Partner on 11 Jul 2020. Ckim Pharma has 5 designated partner changes on record in total.

The registered office of Ckim Pharma is at Namchi Bazar Namchi, Sikkim, India – 737126.

Ckim Pharma operates in the pharma industry, in the drug formulation and development segment.

Ckim Pharma can be reached at its registered office: Namchi Bazar Namchi, Sikkim, India – 737126.